Moreover, 16% of TNBC in this study were reported to have PVs in either BRCA1 or BRCA2. Another study determined TP53 germline variants in a large cohort of 10053 breast cancer in Chinese populations. This evidence concerns the gene BRCA2 and breast carcinoma.